Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc. Ronald R, Gartland M, Li Z, Zhou N, et al. AIDS 2021 Oct 7. pii: 00002030-900000000-96298.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ronald R, Gartland M, Li Z, Zhou N, et al. Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc. AIDS 2021 Oct 7. pii: 00002030-900000000-96298.
PMID: 34628442